NEW YORK (Reuters Health) - Therapy with valacyclovir (Valtrex, GlaxoSmithKline), started within three months of infection with either herpes simplex virus type 1 (HSV-1) or HSV type 2 (HSV-2), ...

For women who are infected with both herpes and HIV, treating the former may go a long way in reducing the overall impact of HIV. A common antiviral medication, valacyclovir (Valtrex), used to treat ...

May 19, 2004 (Boston) — Valacyclovir is equally as effective as ganciclovir in preventing cytomegalovirus (CMV) in renal transplantation, and it may be more cost-effective as well, researchers ...

Feb. 23, 2005 (New Orleans) — One day of high-dose oral valacyclovir treatment significantly decreases the duration of virus shedding that occurs with recurrent herpes labialis and may reduce the ...

NEW YORK (Reuters Health) - Recurrent outbreaks of herpes simplex virus 2 (HSV2), or "genital herpes," can be effectively treated with a one-day course of valacyclovir (sold under the trade name ...

Anti-herpetic agents reduce recurrence of herpes simplex-2 (HSV-2) symptoms but do not completely block subclinical shedding of virus, even at high doses, researchers reported. In three complementary ...

WHAT: Valtrex (valacyclovir hydrochloride) caplets, from GlaxoSmithKline. TREATS: Recurring outbreaks of genital herpes, which afflicts 50 million Americans and infects another half million each year.

Getting your Trinity Audio player ready... Q: I’m a 64-year-old female with shingles. I have severe pain in the breastbone and back and a small rash under my breast. I cannot tolerate Valtrex, which ...

Pre-, post-exposure prophylaxis effective HIV prevention Valacyclovir reduced HIV-1 levels in patients who did not have the herpes simplex virus 2. The results of a new trial show that a common herpes ...

A pill developed to fight herpes might help control the AIDS virus, researchers reported Friday. The drug’s called valacyclovir and it’s prescribed to people with genital herpes and, less often, ...

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, has announced the positive results from a pivotal ...